These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1988520)

  • 1. Macrophage- and oxidant-mediated inhibition of the ability of live Blastomyces dermatitidis conidia to transform to the pathogenic yeast phase: implications for the pathogenesis of dimorphic fungal infections.
    Sugar AM; Picard M
    J Infect Dis; 1991 Feb; 163(2):371-5. PubMed ID: 1988520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastomyces dermatitidis produces melanin in vitro and during infection.
    Nosanchuk JD; van Duin D; Mandal P; Aisen P; Legendre AM; Casadevall A
    FEMS Microbiol Lett; 2004 Oct; 239(1):187-93. PubMed ID: 15451118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between human bronchoalveolar macrophages and Blastomyces dermatitidis conidia: demonstration of fungicidal and fungistatic effects.
    Sugar AM; Picard M; Wagner R; Kornfeld H
    J Infect Dis; 1995 Jun; 171(6):1559-62. PubMed ID: 7769292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental blastomycosis pneumonia in mice by infection with conidia.
    Sugar AM; Picard M
    J Med Vet Mycol; 1988; 26(6):321-6. PubMed ID: 3246623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pulmonary infection in mice inoculated with Blastomyces dermatitidis conidia.
    Williams JE; Moser SA; Turner SH; Standard PG
    Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):500-9. PubMed ID: 8306053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of
    McBride JA; Gauthier GM; Klein BS
    Virulence; 2019 Dec; 10(1):801-809. PubMed ID: 29532714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism.
    Rooney PJ; Sullivan TD; Klein BS
    Mol Microbiol; 2001 Feb; 39(4):875-89. PubMed ID: 11251809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion.
    Klein BS
    Curr Opin Microbiol; 2000 Aug; 3(4):339-43. PubMed ID: 10972490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent patterns of pulmonary blastomycosis induced by conidia and yeasts in athymic and euthymic mice.
    Frey CL; DeMarsh PL; Drutz DJ
    Am Rev Respir Dis; 1989 Jul; 140(1):118-24. PubMed ID: 2526607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic murine pulmonary blastomycosis induced by intratracheally inoculated Blastomyces dermatitidis conidia.
    Williams JE; Moser SA
    Am Rev Respir Dis; 1987 Jan; 135(1):17-25. PubMed ID: 3800145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of Blastomyces dermatitidis in alveolar and peripheral macrophages from patients with blastomycosis.
    Bradsher RW; Balk RA; Jacobs RF
    Am Rev Respir Dis; 1987 Feb; 135(2):412-7. PubMed ID: 3813204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism.
    Sugar AM; Chahal RS; Brummer E; Stevens DA
    Infect Immun; 1983 Sep; 41(3):908-12. PubMed ID: 6885169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D.
    Lekkala M; LeVine AM; Linke MJ; Crouch EC; Linders B; Brummer E; Stevens DA
    Infect Immun; 2006 Aug; 74(8):4549-56. PubMed ID: 16861641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts.
    Drutz DJ; Frey CL
    J Lab Clin Med; 1985 Jun; 105(6):737-50. PubMed ID: 3998623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii.
    Steenbergen JN; Nosanchuk JD; Malliaris SD; Casadevall A
    Infect Immun; 2004 Jun; 72(6):3478-88. PubMed ID: 15155655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attachment of Blastomyces dermatitidis conidia to murine bronchoalveolar macrophages: characterization of binding and elicitation of respiratory burst.
    Sugar AM; Picard M
    Antonie Van Leeuwenhoek; 1990 Jan; 57(1):21-7. PubMed ID: 2164798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using new genetic tools to study the pathogenesis of Blastomyces dermatitidis.
    Brandhorst TT; Rooney PJ; Sullivan TD; Klein BS
    Trends Microbiol; 2002 Jan; 10(1):25-30. PubMed ID: 11755082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant influence of Blastomyces dermatitidis yeast-phase-specific gene BYS1 on morphogenesis and virulence.
    Krajaejun T; Wüthrich M; Gauthier GM; Warner TF; Sullivan TD; Klein BS
    Infect Immun; 2010 Jun; 78(6):2522-8. PubMed ID: 20368350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis.
    Brandhorst TT; Wüthrich M; Warner T; Klein B
    J Exp Med; 1999 Apr; 189(8):1207-16. PubMed ID: 10209038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of fungal pathogenicity: correlation of virulence in vivo, susceptibility to killing by polymorphonuclear neutrophils in vitro, and neutrophil superoxide anion induction among Blastomyces dermatitidis isolates.
    Morrison CJ; Stevens DA
    Infect Immun; 1991 Aug; 59(8):2744-9. PubMed ID: 1649799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.